Millions of patients who are suffering from one or more types of cardiovascular disease may have been prescribed a regular antiplatelet medication such as aspirin, Plavix® or Effient® to prevent heart attacks, stroke and other potentially life-threatening cardiovascular events.1

However, studies have shown that up to 1 in 3 patients may not respond adequately to their antiplatelet medications.2 Patients who do not respond adequately to their antiplatelet therapies may be at significantly greater risk of ischemic events and death.3-6

Accumetrics, a privately-held company based in San Diego, CA, develops, manufactures, and markets the VerifyNow® System, a state-of-the-art platform and comprehensive suite of tests for the assessment of platelet reactivity to all major antiplatelet therapies in minutes.

Today, approximately half of the top 50 U.S. heart hospitals utilize the rapid and easy-to-use VerifyNow System to provide physicians with reliable information to help them understand their patients’ platelet reactivity